Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients With Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial
2016 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Kaye, David, Gerd Hasenfuß, Petr Neuzil, Marco Post, Rob Doughty, Jean-Noel Trochu, Adam Kolodziej et al. "Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients With Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial." Circulation 134, no. 25 (2016):
Documents & Media
Details
- Authors
- Kaye, David; Hasenfuß, Gerd ; Neuzil, Petr; Post, Marco; Doughty, Rob; Trochu, Jean-Noel; Kolodziej, Adam; Westenfeld, Ralf; Penicka, Martin; Rosenberg, Mark; Hausleiter, Joerg; Raake, Philip; Petrie, Mark C.; Bergmann, Martin; Jondeau, Guillaume; Silvestry, Frank; Hayward, Chris
- Issue Date
- 2016
- Status
- published
- Publisher
- Lippincott Williams & Wilkins
- Journal
- Circulation
- Conference Place
- New Orleans, LA
- ISSN
- 1524-4539; 0009-7322
- Extent
- E707
